Overview
Atrial Fibrillation
Cancer Associated Thrombosis
The Promise of Factor XI
Abelacimab: A Novel Anticoagulant
Clinical Development Program
Our Mission
Our Team
Milestones & Achievements
Patient Advocacy
Healthcare Professionals
Healio
https://www.healio.com/news/hematology-oncology/20210719/single-abelacimab-dose-reduces-vte-after-knee-replacement-surgery